تحميل...
Insilico drug repurposing using FDA approved drugs against Membrane protein of SARS-CoV-2
The novel coronavirus (SARS-CoV-2) outbreak has started taking away the millions of lives worldwide. Identification of known and approved drugs against novel coronavirus disease (COVID-19) seems to be an urgent need for the repurposing of the existing drugs. So, here we examined a safe strategy of u...
محفوظ في:
| الحاوية / القاعدة: | J Pharm Sci |
|---|---|
| المؤلفون الرئيسيون: | , , , , , |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
American Pharmacists Association®. Published by Elsevier Inc.
2021
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7934671/ https://ncbi.nlm.nih.gov/pubmed/33684397 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xphs.2021.03.004 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|